PUBLISHER: The Business Research Company | PRODUCT CODE: 1824520
PUBLISHER: The Business Research Company | PRODUCT CODE: 1824520
Clinical decision support systems (CDSS) are computer programs that evaluate data within electronic health records (EHRs) to offer healthcare providers reminders that help them implement evidence-based clinical guidelines at the point of care.
Clinical decision support systems encompass key components such as services, software, and hardware. They come in different models, including knowledge-based and non-knowledge-based CDSS, utilizing various delivery modes such as on-premise and cloud-based systems. On-premise CDSS operates within an enterprise's internal IT infrastructure, specifically utilized in-house. This software is installed and functions on computers within the organization's premises, facilitating medical diagnoses, alerts, reminders, prescription decision support, information retrieval, and other applications prevalent in clinics, hospitals, ambulatory surgical centers, and similar end-user environments.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The clinical decision support systems market research report is one of a series of new reports from The Business Research Company that provides clinical decision support systems market statistics, including clinical decision support systems industry global market size, regional shares, competitors with a clinical decision support systems market share, detailed clinical decision support systems market segments, market trends and opportunities, and any further data you may need to thrive in the clinical decision support systems industry. This clinical decision support systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The clinical decision support systems market size has grown rapidly in recent years. It will grow from $3.14 billion in 2024 to $3.51 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to increased healthcare data, advancements in medical knowledge, patient safety concerns, healthcare cost pressures, demand for evidence-based medicine.
The clinical decision support systems market size is expected to see rapid growth in the next few years. It will grow to $5.72 billion in 2029 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to precision medicine initiatives, value-based care models, real-time decision support, population health management, interoperability initiatives, cybersecurity concerns. Major trends in the forecast period include mobile and cloud-based cuss solutions, clinical workflow optimization, patient-centric cuss applications, real-time analytics for clinical insights, collaboration with telehealth services.
The forecast of 13.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. patient safety by inflating prices of Artificial Intelligence (AI)-powered diagnostic algorithms and drug interaction databases developed in Israel and the Netherlands, resulting in reduced decision-making accuracy and higher Electronic Health Record(EHR) integration costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing adoption of information systems by hospitals is anticipated to drive the growth of the clinical decision support systems market in the future. Information systems encompass the software and hardware used to collect, store, and process data. Healthcare facilities are implementing these systems to ensure smooth operations and seamless clinical data flow. For example, in February 2023, Rock Health, a UK-based corporation, reported in its 2022 survey that 80% of respondents had used telemedicine at some point in their lives, marking an 8-percentage point increase from 72% in 2021. Additionally, the use of live video telemedicine remained consistent in 2022, with only a slight increase of 1 percentage point compared to 2021. Therefore, the rise in information systems adoption by hospitals is fostering growth in the clinical decision support systems market.
The surge in demand for cloud computing is poised to significantly propel the expansion of the clinical decision support systems (CDSS) market. Cloud computing, a technology facilitating the delivery of diverse computing services over the internet, is extensively employed by organizations and individuals to oversee and invest in physical hardware and software infrastructure. Within CDSS, cloud computing plays a pivotal role, enabling healthcare entities to securely store extensive volumes of patient data, medical records, and pertinent information on centralized cloud servers. For example, as per Google LLC, a US-based technology company, in January 2023, the utilization of the public cloud witnessed a notable ascent, with 76% of individuals leveraging this technology in 2022, marking a 56% increase from the preceding year. Hence, the escalating demand for cloud computing stands as a driving force behind the burgeoning growth of the clinical decision support systems market.
Advancements in technology have emerged as the predominant trend driving traction within the clinical decision support systems market. Key players within this sector are directing their efforts toward innovating and introducing novel technological solutions to bolster their market standing. For instance, in April 2022, Change Healthcare, a prominent US-based healthcare technology company, unveiled InterQual, a clinical decision support solution geared toward evidence-based care. This offering incorporates interactive and revamped criteria aimed at optimizing workflow efficiency, along with the integration of artificial intelligence to facilitate proactive insights. Notably, this technology has the capability to predict whether a patient necessitates observation, or whether their condition warrants a short-term or long-term stay, showcasing the strides made in predictive capabilities within clinical decision support systems.
Leading companies in the clinical decision support systems market are concentrating on launching advanced solutions, such as insulin dosing software, to secure a competitive advantage. Insulin dosing software is a specialized clinical decision support system designed to aid healthcare providers in calculating and administering the correct insulin dosages for patients, ensuring personalized and safe glycemic management. For example, in April 2023, Glytec, a US-based platform, released the latest version of its Glucommander insulin dosing platform. Glucommander is a cloud-based insulin dosing software developed by Glytec that offers personalized intravenous (IV) and subcutaneous (SubQ) insulin dosing for patients, irrespective of their diabetes status. It integrates with electronic health record (EHR) systems to enhance clinical workflows and improve patient safety in glycemic management.
In October 2024, VitalHub Corp., a US-based healthcare technology company, acquired MedCurrent Corporation for an undisclosed amount. This acquisition is part of VitalHub's strategy to integrate advanced technology solutions to improve healthcare delivery. MedCurrent Corporation, also a US-based healthcare technology firm, specializes in providing clinical decision support.
Major companies operating in the clinical decision support systems market include McKesson Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Hera-MI LLC, Cerner Corporation, Epic Systems Corporation, Elsevier B.V., Change Healthcare Corporation, Allscripts Healthcare Solutions Inc., Athenahealth Inc., Wolters Kluwer Health, Premier Inc., eClinicalWorks Inc., Veradigm Inc., NextGen Healthcare Inc., Medical Information Technology Inc., Meditech Systems Network Inc., Health Catalyst, CareCloud Inc., CureMD Inc., Strata Decision Technology, Zynx Health, First Databank Inc., Clinical Architecture Inc., VisualDx Group Inc., Apervita Inc., IBM Watson Health, The Medical Algorithms Company LP, RAMPmedical Inc.
North America was the largest region in the clinical decision support systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical decision support systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the clinical decision support systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The clinical decision support systems (CDSS) market consists of sales of knowledge based CDSS, and non knowledge-based CDSS. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Clinical Decision Support Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on clinical decision support systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for clinical decision support systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clinical decision support systems market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.